Fractyl Health, Inc. (GUTS) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to Fractal's Health First Quarter 2026 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, all participants are in listen-only mode. There will be a Q&A session following management's prepared remarks. I'll now turn the call over to Brian Luque, Head of Investor Relations and Corporate Development at Fractal. Brian, you may now begin. Thank you. This afternoon, we issued a press release that outlines the topics we plan to discuss today. This release is available at www.fractal.com under the Investors tab. Joining us on the call today are Dr. Harith Rajagopalan, Chief Executive Officer, and Laura Smith-Weber, Chief Financial Officer. During this call, we make forward-looking statements which involve risks and uncertainties that may cause our actual results to differ materially when those expressed are implied by forward-looking statements. A discussion of these risks and uncertainties is included in our filing with the SEC from time to time, including the section titled Risk Factors in our annual report on Form 10-K for the year ended December 31st, 2025, and our quarterly report on Form 10-Q filed today, which I encourage you to review. Any forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as the call's original date, and we undertake no obligation to update or revise any of the statements, even if subsequent events cause our views to change. It is now my pleasure to pass the call over to Harith. Thank you, Brian. Good afternoon, everyone. Tens of millions of Americans are now on GLP-1 therapy, and over 1 million people are discontinuing GLP-1s each month in the United States. What happens next is increasingly well characterized...